Differential diagnosis of skin lesions after allogeneic haematopoietic stem cell transplantation

被引:18
作者
Canninga-van Dijk, MR
Sanders, CJ
Verdonck, LF
Fijnheer, R
van den Tweel, JG
机构
[1] Univ Med Ctr, Dept Pathol, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr, Dept Dermatol, NL-3508 GA Utrecht, Netherlands
[3] Univ Med Ctr, Dept Haematol, NL-3508 GA Utrecht, Netherlands
关键词
stem cell transplantation; skin; complications; graft-versus-host disease; histopathology;
D O I
10.1046/j.1365-2559.2003.01591.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Allogeneic haematopoietic stem cell transplantation (i.e. bone marrow or peripheral blood stem cell transplantation) is a common procedure in the treatment of various haematological disorders such as aplastic anaemia, (pre)leukaemias, some malignant lymphomas, multiple myeloma and immunodeficiency states. Many of these patients develop erythematous skin lesions following transplantation. Although graft- versus-host disease is the major differential diagnosis in these situations, many other causes of erythema are encountered. The large number of transplant patients means that more and more pathologists are confronted with the challenging problem of making a correct diagnosis in these situations. In this review article we therefore describe the different causes of erythema and their differential diagnoses. In most cases the clinical presentation is related to the microscopical features. Besides acute and chronic graft-versus-host disease, we discuss the (common) drug reactions and non-specific features such as Sweet's syndrome, erythema nodosum and eosinophilic folliculitis. In addition, we deal with the recurrence of original diseases and infections. With this knowledge every pathologist should feel comfortable when looking at skin biopsies of patients after haematological stem cell transplantation.
引用
收藏
页码:313 / 330
页数:18
相关论文
共 152 条
[1]  
ACKERMAN AB, 1977, CANCER, V40, P813, DOI 10.1002/1097-0142(197708)40:2<813::AID-CNCR2820400233>3.0.CO
[2]  
2-T
[3]   Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy [J].
Adkins, DR ;
Abidi, MH ;
Brown, RA ;
Khoury, H ;
Goodnough, LT ;
Vij, R ;
Westervelt, P ;
DiPersio, JF .
BONE MARROW TRANSPLANTATION, 2000, 26 (11) :1239-1241
[4]   IN-UTERO ACUTE GRAFT-VERSUS-HOST DISEASE IN A NEONATE WITH SEVERE COMBINED IMMUNODEFICIENCY [J].
ALAIN, G ;
CARRIER, C ;
BEAUMIER, L ;
BERNARD, J ;
LEMAY, M ;
LAVOIE, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 29 (05) :862-865
[5]   Transfer of vitiligo after allogeneic bone marrow transplantation [J].
Alajlan, A ;
Alfadley, A ;
Pedersen, KT .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (04) :606-610
[6]   VERRUCIFORM XANTHOMA IN A BONE-MARROW TRANSPLANT RECIPIENT [J].
ALLEN, CM ;
KAPOOR, N .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1993, 75 (05) :591-594
[7]   Macroscopic and microscopic mucinosis in chronic sclerodermoid graft-versus-host disease [J].
Ameen, M ;
Russell-Jones, R .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (03) :529-532
[8]  
Andrews M L, 1997, Australas J Dermatol, V38, P53, DOI 10.1111/j.1440-0960.1997.tb01107.x
[9]  
Andrews ML, 1997, AUSTRALAS J DERMATOL, V38, P63
[10]   Treatment of cutaneous T cell lymphoma: Current status and future directions [J].
Apisarnthanarax N. ;
Talpur R. ;
Duvic M. .
American Journal of Clinical Dermatology, 2002, 3 (3) :193-215